Literature DB >> 1974962

In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy.

W Grodd, I Krägeloh-Mann, D Petersen, F K Trefz, K Harzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1974962     DOI： 10.1016/0140-6736(90)91982-g

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

Review 1.  Biochemistry and molecular biology of Canavan disease.

Authors:  R Matalon; K Michals-Matalon
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 2.  Leukoencephalopathies and metabolic diseases.

Authors:  Antonio Giorgio; Nicola De Stefano
Journal:  Neurol Sci       Date:  2008-10       Impact factor: 3.307

3.  Development and aging of the cerebrum: assessment with proton MR spectroscopy.

Authors:  T Kadota; T Horinouchi; C Kuroda
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

4.  Restricted diffusion in Canavan disease.

Authors:  S G Srikanth; H S Chandrashekar; K Nagarajan; P N Jayakumar
Journal:  Childs Nerv Syst       Date:  2007-01-12       Impact factor: 1.475

Review 5.  MR spectroscopy: a powerful tool for investigating brain function and neurological diseases.

Authors:  A P Burlina; T Aureli; F Bracco; F Conti; L Battistin
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

6.  Abnormally high levels of brain N-acetylaspartate in children with sickle cell disease.

Authors:  R Grant Steen; Robert J Ogg
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

Review 7.  [Magnetic resonance spectroscopy of brain tumours].

Authors:  I Harting; G Jost; N Hacke; M Hartmann
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

Review 8.  Pediatric neurodegenerative white matter processes: leukodystrophies and beyond.

Authors:  Jonathan A Phelan; Lisa H Lowe; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2008-04-30

9.  A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice.

Authors:  Seemin Seher Ahmed; Huapeng Li; Chunyan Cao; Elif M Sikoglu; Andrew R Denninger; Qin Su; Samuel Eaton; Ana A Liso Navarro; Jun Xie; Sylvia Szucs; Hongwei Zhang; Constance Moore; Daniel A Kirschner; Thomas N Seyfried; Terence R Flotte; Reuben Matalon; Guangping Gao
Journal:  Mol Ther       Date:  2013-07-02       Impact factor: 11.454

Review 10.  Canavan disease: biochemical and molecular studies.

Authors:  R Matalon; R Kaul; K Michals
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.